IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,424,000 | +118.9% | 82,186 | +131.7% | 0.02% | +114.3% |
Q1 2018 | $1,564,000 | +6.2% | 35,476 | +21.3% | 0.01% | 0.0% |
Q4 2017 | $1,472,000 | +110.9% | 29,249 | +100.3% | 0.01% | +40.0% |
Q4 2016 | $698,000 | +45.4% | 14,600 | +11.5% | 0.01% | +25.0% |
Q3 2016 | $480,000 | -4.4% | 13,100 | +61.7% | 0.00% | +100.0% |
Q4 2015 | $502,000 | – | 8,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |